ONCOLYTICS BIOTECH INC (ONC.CA) Stock Income Statement
TSX:ONC - CA6823108759 - Common Stock
1.42 CAD
+0.03 (+2.16%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 31.04M | 34.98M | 33.79M | 26.92M | 26.23M | |||
| Research and Development | 18.24M | 21.65M | 17.71M | 15.43M | 12.92M | |||
| Selling, General, and Administrative Expenses | 12.41M | 12.42M | 3.94M | 11.10M | 12.86M | |||
| Operating Income | -31.04M | -34.98M | -33.79M | -26.92M | -26.23M | |||
| Interest Income/Expense | 796.00K | 3.40M | 6.14M | 2.17M | -20.00K | |||
| Income Before Taxes | -30.29M | -31.58M | -27.66M | -24.75M | -26.25M | |||
| Income Tax | N/A | 130.00K | 97.00K | 80.00K | 50.00K | |||
| Net Income | -30.41M | -31.71M | -27.75M | -24.84M | -26.30M | |||
| EBITDA | -30.65M | -34.56M | -33.39M | -26.53M | -25.78M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.37 | -0.41 | -0.41 | -0.43 | -0.49 | |||
| Non GAAP EPS | -0.37 | -0.41 | -0.41 | -0.44 | -0.49 | |||
| Statistics | ||||||||
All data in CAD